US Bancorp’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

US Bancorp’s Portfolio ONCY Stock Details ONCY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-5,000	Closed	-$12K	–	3534
2013 Q3	$12K	Buy	+5,000	New	+$13.8K	﹤0.01%	2845

Other funds holding ONCY

1832 Asset Management Toronto, Ontario, Canada $199B AUM 37.98% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

RFC

Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

AII

AGF Investments Inc Toronto, Ontario, Canada $10.6B AUM 4.37% 1-Year Est. Return

Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return

First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $62.7B AUM 37.65% 1-Year Est. Return

Sophrosyne Capital New York $11.5M AUM 17.82% 1-Year Est. Return

IGIM

I.G. Investment Management Winnipeg, Manitoba, Canada $19.5B AUM 15.95% 1-Year Est. Return

US Bancorp's ONCY Position: Q4 2013 in Review

US Bancorp sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q4 2013, closing a stake of 5,000 shares — an estimated $12K sold.

US Bancorp first reported a position in ONCY in Q3 2013 and held it in 1 quarter. The position peaked at $12K in Q3 2013. 37 funds tracked by Wall St. Rank hold ONCY as of Q4 2013.

US Bancorp reported no remaining ONCOLYTICS BIOTECH INC position as of Q4 2013 after selling out during the quarter.
US Bancorp sold 5,000 ONCOLYTICS BIOTECH INC shares in Q4 2013, an estimated $12K.
US Bancorp first reported a position in ONCOLYTICS BIOTECH INC in Q3 2013 and held it in 1 quarter.
US Bancorp's ONCOLYTICS BIOTECH INC position peaked at $12K in Q3 2013.
37 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q4 2013.

Based on US Bancorp's 13F filing for Q4 2013, filed 13 Feb 2014.